Italy · Investor

Panakes Partners

Last cheque observed Oct 2026; 6 cheques on record.

Deploying nowNew fund $9.5M, Oct 2026VC firm

Pre-seedSeedSeries AGene TherapyPharmaceuticalsIn Vitro Diagnostics

Deploying now
100%of best year2cheques in 12 months, 6 on record
Since the last cheque7days00hrs00min00sec
Median round$51MCheque size, as they say$3.0M – $8.0MRounds led1 of 6Mostly inSwitzerland, 33%
Pitch Panakes Partners

Panakes Partners highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 67% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
$3.0M – $8.0M as they say
Stages
Pre-seedSeedSeries A
Sectors
Gene TherapyPharmaceuticalsIn Vitro Diagnostics
Based in
Milan, Italy
Cold pitches
Not stated

The record

Every round we can evidence, newest first6 appearances

  1. 2026

    2 rounds

  2. Oct
    NouscomSeries D · CH · Revelation Partners$135MWith 14 others
  3. Apr
    Endovascular Engineering, Inc. (“E2”)Series C · US · Firms' own news pages$80MWith 6 others
  4. 2025

    2 rounds

  5. May
    Salvia BioElectronicsSeries B · NL · Thuja Capital$60MWith 9 others
  6. Feb
    Endovascular EngineeringSeries B · US · Firms' own news pages$42MWith 5 others
  7. 2019

    1 round

  8. May
    SamanTree MedicalSeries A · CH · FinSMEs$9.5MLed
  9. 2018

    1 round

  10. Dec
    CarTheraSeries B · FR · FinSMEs$10MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who backs their funds

1 LP on record in Panakes Partners's funds

Funds
1

The institutions that put money into its funds, which the firm then invests in companies.Source: an LP list.

Who they invest alongside

The investors most often in the same rounds as Panakes Partners. A count of rooms they were both in, not a relationship either has claimed.

415 CapitalVC firm2rounds togetherSante VenturesVC firm2rounds together

Recently backed

The latest companies Panakes Partners put money into.

Nouscom$135M · Oct 2026Salvia BioElectronics$60M · May 2025SamanTree Medical$9.5M · May 2019CarThera$10M · Dec 2018

Quick answers about Panakes Partners

What does Panakes Partners invest in?

Panakes Partners invests most often at Series B and Series A (67% of the rounds on record), in sectors such as Gene Therapy, Pharmaceuticals and In Vitro Diagnostics.

How active is Panakes Partners?

6 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Oct 2026.

What has Panakes Partners invested in recently?

Its most recent investments on record: Nouscom (Series D, Oct 2026), Endovascular Engineering, Inc. (“E2”) (Series C, Apr 2026) and Salvia BioElectronics (Series B, May 2025).

How big are Panakes Partners's cheques?

The median round it joins is $51M. It says it writes cheques of $3.0M to $8.0M.

Does Panakes Partners lead rounds?

Yes: it led 1 of its 6 investments on record (17%).

Where does Panakes Partners invest?

Most of the companies it backs are in Switzerland (33%), the United States (33%) and the Netherlands (17%).

Is Panakes Partners investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does Panakes Partners invest alongside?

Most often 415 Capital (2 rounds together) and Sante Ventures (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it